A Novel Phthalimide Derivative, TC11, Has Preclinical Effects on High-Risk Myeloma Cells and Osteoclasts

A Novel Phthalimide Derivative, TC11, Has Preclinical Effects on High-Risk Myeloma Cells and Osteoclasts

Despite the recent advances in the treatment of multiple myeloma (MM), MM patients with high-risk cytogenetic changes such as t(4;14) translocation or deletion of chromosome 17 still have extremely poor prognoses. With the goal of helping these high-risk MM patients, we previously developed a novel...

Full description

Bibliographic Details
Main Authors: Matsushita, Maiko, Ozaki, Yoshie, Hasegawa, Yuka, Terada, Fukiko, Tabata, Noriko, Shiheido, Hirokazu, Yanagawa, Hiroshi, Oikawa, Tsukasa, Matsuo, Koichi, Du, Wenlin, Yamada, Taketo, Hozumi, Masashi, Ichikawa, Daiju, Hattori, Yutaka
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305313/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305313/

Similar Items